Concepedia

Terrence L. Fisher

TL

13

Publications

675

Citations

13

H-Index

2001

Active since

Affiliations

Vaccinex (United States)(Current)

University of Rochester Medical Center

University of Rochester

Terrence L. Fisher is an author at Vaccinex (United States) specializing in allergy, medicine, and autoimmunity.

ORCID

Top concepts

Publications per year

2001–2022

13

Publications

13

SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease

Ernest Smith, Alan S. Jonason, Christine Reilly et al. · Neurobiology of Disease · 2014 · 112 citations · Full text

Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

Elizabeth E. Evans, Alan S. Jonason, Sebold Torno et al. · Cancer Immunology Research · 2015 · 105 citations · Full text

Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors

Amita Patnaik, Glen J. Weiss, John E. Leonard et al. · Clinical Cancer Research · 2015 · 64 citations · Full text

Safety/tolerability of the anti-semaphorin 4D antibody VX15/2503 in a randomized phase 1 trial

Christopher LaGanke, Lawrence Samkoff, Keith R. Edwards et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 58 citations · Full text

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher et al. · Nature Medicine · 2022 · 57 citations · Full text

Rows per page

1–5 of 13